Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

4.3%

Beneficial ownership of this reported class.

Shares

8,322,179 shares

Shares beneficially owned as disclosed.

Event date

30 Sep 2025

Date tied to the ownership event or amendment.

Accepted by SEC

14 Nov 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
BMRN
Shares outstanding
193,539,047 shares
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
14 Nov 2025, 16:53:40 UTC
Event date
30 Sep 2025
Prior SEC filing
14 Aug 2025
Source filing
View source filing
Filing notes and source

Key filing fact

VIKING GLOBAL INVESTORS LP disclosed 4.3% ownership in BIOMARIN PHARMACEUTICAL INC Common Stock, par value $0.001 per share (BMRN) on 30 Sep 2025.

Key facts

  • VIKING GLOBAL INVESTORS LP filed SCHEDULE 13G/A for BIOMARIN PHARMACEUTICAL INC Common Stock, par value $0.001 per share (BMRN).
  • Disclosed ownership: 4.3%.
  • Date of event: 30 Sep 2025.

Change

  • Disclosed shares changed by -3,966,432 since the prior disclosure.
  • Previous schedule filing date: 14 Aug 2025.
  • Current filing was accepted on 14 Nov 2025, 16:53.
  • Disclosed stake changed by -2.10 percentage points.
  • Changes between disclosures can reflect transactions, share-count changes or reporting changes; they do not establish a purchase or activist intent.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (13)

Names, ownership percentages, voting power, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power CIK
VIKING GLOBAL INVESTORS LP 4.3% 8,322,179 0 8,322,179
VIKING GLOBAL PERFORMANCE LLC 2.8% 5,397,003 0 5,397,003
Viking Global Equities II LP 0.1% 107,937 0 107,937
Viking Global Equities Master Ltd. 2.8% 5,289,066 0 5,289,066
Viking Long Fund GP LLC 1.1% 2,094,037 0 2,094,037
Viking Long Fund Master Ltd. 1.1% 2,094,037 0 2,094,037
Viking Global Opportunities Parent GP LLC 0.4% 831,139 0 831,139
Viking Global Opportunities GP LLC 0.4% 831,139 0 831,139
Viking Global Opportunities Portfolio GP LLC 0.4% 831,139 0 831,139
Viking Global Opportunities Liquid Portfolio Sub-Master LP 0.4% 831,139 0 831,139
HALVORSEN OLE ANDREAS 4.3% 8,322,179 0 8,322,179
Ott David C. 4.3% 8,322,179 0 8,322,179
Shabet Rose Sharon 4.3% 8,322,179 0 8,322,179
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .